Skip to main content

Oncology: Cancer Stage Documented

CBE ID
0386
1.4 Project
Endorsed
Endorsement Status
1.1 New or Maintenance
E&M Cycle
Is Under Review
No
1.3 Measure Description

Percentage of patients, regardless of age, with a diagnosis of cancer who are seen in the ambulatory setting who have cancer staging documented using any standardized system or documentation that the cancer is metastatic in the medical record within one month of first office visit

        • 1.14 Numerator

          Patients who have cancer staging documented using any standardized system or documentation that the cancer is metastatic in the medical record within one month of the first office visit

        • 1.15 Denominator

          All patients, regardless of age, with a diagnosis of cancer who are seen in the ambulatory setting.

        • Exclusions

          Patients with a documented case of leukemia, myeloma, or myelodysplastic syndromes (MDS).

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed Cancer Fall Cycle 2019
          Initial Endorsement
          Last Updated
          Removal Date
        • Steward Organization Email
          Steward Organization Copyright

          © 2018 American Medical Association and American Society of Clinical Oncology. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

          Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, ASCO, the PCPI and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT®) or other coding contained in the specifications.

          CPT® contained in the Measures specifications is copyright 2004-2018 American Medical Association. LOINC® copyright 2004-2018 Regenstrief Institute, Inc. SNOMED CLINICAL TERMS (SNOMED CT®) copyright 2004-2018 College of American Pathologists. All Rights Reserved.